ISOTRETINOIN MEDICATION PROGRAM: ALERTING YOU TO THE RISKS OF TERATOGENICITY (I.M.P.A.R.T.)

Welcome to the Brand page for “ISOTRETINOIN MEDICATION PROGRAM: ALERTING YOU TO THE RISKS OF TERATOGENICITY (I.M.P.A.R.T.)”, which is offered here for Printed instructional and educational materials used for counseling to healthcare professionals to provide patients with information on the importance of pregnancy prevention while undergoing treatment with a pharmaceutical preparation associated with fetal abnormalities;isotretinoin medication program: alerting you to the risks of teratogenicity impart;isotretinoin medication program: alerting you to the risks of teratogenicity;.

Its status is currently believed to be active. Its class is unavailable. “ISOTRETINOIN MEDICATION PROGRAM: ALERTING YOU TO THE RISKS OF TERATOGENICITY (I.M.P.A.R.T.)” is believed to be currently owned by “Ranbaxy Laboratories Limited”.